SonoSite hires Pitz as senior VP, CFO

TriMed Staff | | Health Imaging | Artificial Intelligence
Bernard J. Pitz today joined SonoSite as senior vice president and chief financial officer (CFO).

After serving as CFO for eight years, Mike Schuh will move into a new executive position in the company overseeing business process, according to the Bothell, Wash.-based SonoSite.

Pitz’s career spans 26 years in global finance positions in the telecommunications, software, wireless technology and medical technology industries, SonoSite said. Most recently, Pitz served as vice president, finance, CFO and treasurer with Sybron Dental Specialties, a manufacturer of high technology dental, orthodontic, dental implant and infection prevention products, according to the company.

TriMed Staff

Related Content

New cardiac prevention paradigm explored in TRANSFORM trial using AI and CCTA
PHOTO GALLERY: Medical imaging technology at RSNA 2024
Cardiology, radiology specialists debate CCTA’s rise as a go-to imaging modality for CAD
Can large language models break language barriers in radiology reports?
Most patients want to know if AI is involved in their care
New algorithm is twice as accurate at predicting stroke timing compared to the standard of care

Around the web

Radiology Business
The biggest challenges facing radiology business managers in 2025

RBMA President Peter Moffatt discusses some of the biggest obstacles facing the specialty in the new year. 

Cardiovascular Business
New cardiac prevention paradigm explored in TRANSFORM trial using AI and CCTA

Deepak Bhatt, MD, director of the Mount Sinai Fuster Heart Hospital and principal investigator of the TRANSFORM trial, explains an emerging technique for cardiac screening: combining coronary CT angiography with artificial intelligence for plaque analysis to create an approach similar to mammography.

Cardiovascular Business
Cardiology practices pay $17.7M to settle fraud allegations brought on by whistleblowers

A total of 16 cardiology practices from 12 states settled with the DOJ to resolve allegations they overbilled Medicare for imaging agents used to diagnose cardiovascular disease.